Effects of Lactobacillus acidophilus NCFM on insulin sensitivity and the systemic inflammatory response in human subjects
暂无分享,去创建一个
N. Larsen | A. S. Andreasen | B. Pedersen | M. Jakobsen | K. Møller | K. D. Svendsen | Theis Pedersen-Skovsgaard | R. Berg | K. Svendsen
[1] Patrice D Cani,et al. The role of the gut microbiota in energy metabolism and metabolic disease. , 2009, Current pharmaceutical design.
[2] Sue Abell,et al. Probiotics , 2009, Clinical pediatrics.
[3] P. Moseley,et al. The effect of glutamine infusion on the inflammatory response and HSP70 during human experimental endotoxaemia , 2009, Critical care.
[4] W. D. de Vos,et al. S layer protein A of Lactobacillus acidophilus NCFM regulates immature dendritic cell and T cell functions , 2008, Proceedings of the National Academy of Sciences.
[5] Xiong Ma,et al. Probiotics improve high fat diet-induced hepatic steatosis and insulin resistance by increasing hepatic NKT cells. , 2008, Journal of hepatology.
[6] B. Ravikumar,et al. Clinical Diabetes Research: Methods and Techniques , 2008 .
[7] A. Ouwehand,et al. Influence of a combination of Lactobacillus acidophilus NCFM and lactitol on healthy elderly: intestinal and immune parameters. , 2008, The British journal of nutrition.
[8] A. S. Andreasen,et al. Human endotoxemia as a model of systemic inflammation. , 2008, Current medicinal chemistry.
[9] H. Yadav,et al. Oral administration of dahi containing probiotic Lactobacillus acidophilus and Lactobacillus casei delayed the progression of streptozotocin-induced diabetes in rats , 2008, Journal of Dairy Research.
[10] Essam M. Hamad,et al. Effects of milk fermented byLactobacillusgasseri SBT2055 on adipocyte size in rats , 2008, British Journal of Nutrition.
[11] H. Yadav,et al. The effect of probiotic dahi containing Lactobacillus acidophilus and Lactobacillus casei on gastropathic consequences in diabetic rats. , 2008, Journal of medicinal food.
[12] M. Membrez,et al. Gut microbiota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[13] Jeremy K. Nicholson,et al. Gut microbiota: a potential new territory for drug targeting , 2008, Nature Reviews Drug Discovery.
[14] W. Walker. Mechanisms of action of probiotics. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[15] L. N. Fink,et al. Human antigen-presenting cells respond differently to gut-derived probiotic bacteria but mediate similar strain-dependent NK and T cell activation. , 2007, FEMS immunology and medical microbiology.
[16] M. Roden,et al. Glucose Clamp Techniques , 2007 .
[17] C. Knauf,et al. Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia , 2007, Diabetologia.
[18] J. Xaus,et al. Two Lactobacillus strains, isolated from breast milk, differently modulate the immune response , 2007, Journal of applied microbiology.
[19] B. Pedersen,et al. Human Models of Low-Grade Inflammation: Bolus versus Continuous Infusion of Endotoxin , 2007, Clinical and Vaccine Immunology.
[20] Jeffrey I. Gordon,et al. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice , 2007, Proceedings of the National Academy of Sciences.
[21] E. Mardis,et al. An obesity-associated gut microbiome with increased capacity for energy harvest , 2006, Nature.
[22] G. Hotamisligil,et al. Inflammation and metabolic disorders , 2006, Nature.
[23] H. Harmsen,et al. Antibiotic treatment partially protects against type 1 diabetes in the Bio-Breeding diabetes-prone rat. Is the gut flora involved in the development of type 1 diabetes? , 2006, Diabetologia.
[24] M. Kleerebezem,et al. Towards understanding molecular modes of probiotic action. , 2006, Current opinion in biotechnology.
[25] R. Barrangou,et al. INAUGURAL ARTICLE by a Recently Elected Academy Member:Complete genome sequence of the probiotic lactic acid bacterium Lactobacillus acidophilus NCFM , 2005 .
[26] Ting Wang,et al. The gut microbiota as an environmental factor that regulates fat storage. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[27] J. Pickup. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. , 2004, Diabetes care.
[28] Z. Bloomgarden,et al. Inflammation and insulin resistance. , 2003, Diabetes care.
[29] F. Guarner,et al. Gut flora in health and disease , 2003, The Lancet.
[30] C. De Simone,et al. Probiotic bacteria enhance murine and human intestinal epithelial barrier function. , 2001, Gastroenterology.
[31] J. Walter,et al. Detection of Lactobacillus, Pediococcus, Leuconostoc, and Weissella Species in Human Feces by Using Group-Specific PCR Primers and Denaturing Gradient Gel Electrophoresis , 2001, Applied and Environmental Microbiology.
[32] P. Ricciardi-Castagnoli,et al. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria , 2001, Nature Immunology.
[33] M. Sanders,et al. Invited review: the scientific basis of Lactobacillus acidophilus NCFM functionality as a probiotic. , 2001, Journal of dairy science.
[34] N. Mackman,et al. LPS induction of gene expression in human monocytes. , 2001, Cellular signalling.
[35] F. Ampe,et al. Microbial Community Dynamics during Production of the Mexican Fermented Maize Dough Pozol , 2000, Applied and Environmental Microbiology.
[36] K. Michaelsen,et al. Screening of Probiotic Activities of Forty-Seven Strains of Lactobacillus spp. by In Vitro Techniques and Evaluation of the Colonization Ability of Five Selected Strains in Humans , 1999, Applied and Environmental Microbiology.
[37] A Mari,et al. How to measure insulin sensitivity , 1998, Journal of hypertension.
[38] J. Pickup,et al. NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X , 1997, Diabetologia.
[39] B. Spiegelman,et al. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. , 1995, The Journal of clinical investigation.
[40] A. Uitterlinden,et al. Profiling of complex microbial populations by denaturing gradient gel electrophoresis analysis of polymerase chain reaction-amplified genes coding for 16S rRNA , 1993, Applied and environmental microbiology.
[41] R. DeFronzo,et al. Glucose clamp technique: a method for quantifying insulin secretion and resistance. , 1979, The American journal of physiology.
[42] H. Yadav,et al. Antidiabetic effect of probiotic dahi containing Lactobacillus acidophilus and Lactobacillus casei in high fructose fed rats. , 2007, Nutrition.